Life Science Business

Research and development, manufacture and sales of pharmaceuticals, health foods and cosmetics in collaboration with various business partners.

In the biotechnology field, while the SBI Group will focus on the investment and nurturing of promising bio-venture companies, and will pursue stable sustained growth, biotechnology itself has been positioned as a high-priority business segment, and through the establishment of subsidiaries, the Group has embarked into the Biotechnology-related Business on an operating basis, The SBI Group is engaged in the Biotechnology-related Business through three main subsidiaries. SBI Biotech, established in 2007, develops new medical are and pharmaceutical products through the utilization of its leading edge biotechnologies. In the 5-ALA-related business, SBI Pharmaceuticals, established in 2008, is engaged in the research, development and manufacture of pharmaceuticals, health foods and cosmetics using 5-ALA, and SBI ALApromo, established in 2012, distributes health foods and cosmetics containing 5-ALA in Japan.

The Biotechnology-related Business contributes to healthy living through the research, development and manufacture of pharmaceuticals, health foods and cosmetics, moreover the pharmaceutical industry is said to be a defensive sector that is resistant to economic fluctuations, and may be considered a sector that is conducive to stable profit generation, since profit margins are higher than that of other business sectors in Japan. Furthermore, in the 5-ALA-related business, which is expected to drive the medium and long-term growth of the SBI Group, the application of the active ingredient 5-ALA in a wide range of fields is attracting considerable attention, and the number of joint research business partners in Japan and overseas are increasing. Going forward, the integration of the research structure to accelerate the globalization process, and the strengthening of the sales structure for pharmaceuticals, health foods and other products will be accomplished in Japan and abroad.

  • Research and development of medical treatments and pharmaceutical products that utilize leading-edge biotechnologies
  • Research and development of pharmaceuticals, health foods and cosmetics containing 5-ALA